title: MARIANNE: Impact on Current Treatment of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Implications for the Future.
authors.affiliation: Komal Jhaveri, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.
authors.forename: Komal
authors.initials: K
authors.lastname: Jhaveri
mesh_terms: D000080044:Ado-Trastuzumab Emtansine; D061067:Antibodies, Monoclonal, Humanized; D001943:Breast Neoplasms; D006801:Humans; D008453:Maytansine / Q000031:analogs & derivatives; D018719:Erb-b2 Receptor Tyrosine Kinases; D043823:Taxoids; D000068878:Trastuzumab
chemical_list: D000080044:Ado-Trastuzumab Emtansine; D061067:Antibodies, Monoclonal, Humanized; D008453:Maytansine; D018719:Erb-b2 Receptor Tyrosine Kinases; D043823:Taxoids; D000068878:Trastuzumab; C508053:ERBB2 protein, human; C485206:pertuzumab